Aug 28, 2026 06:40PM
Aug 28, 2026 06:40PM
Aug 24, 2026 02:36AM
Aug 5, 2026 06:10PM
Aug 5, 2026 06:10PM
Jul 30, 2026 02:37AM
Jul 16, 2026 06:00PM Takeda psoriasis drug shows skin clearance in Phase 3 trials
Jul 16, 2026 06:00PM
Jul 12, 2026 07:00PM
Jun 24, 2026 03:14AM
Jun 24, 2026 03:05AM
Jun 15, 2026 12:00PM
Jun 11, 2026 07:00AM
Jun 11, 2026 07:00AM Takeda’s Zasocitinib Significantly Outperforms Deucravacitinib in Head-to-Head Phase 3 Psoriasis Study, Promising to Redefine Oral Treatment Expectations
Jun 9, 2026 04:30PM
Jun 9, 2026 04:30PM
May 13, 2026 05:46AM
May 13, 2026 02:38AM
May 4, 2026 08:00AM
May 4, 2026 08:00AM
Mar 30, 2026 04:21AM Takeda (TAK) Takeda's zasocitinib shows clear skin results in psoriasis trials
Mar 28, 2026 03:00PM
Mar 2, 2026 06:01AM
Mar 2, 2026 02:00AM
Feb 19, 2026 12:00PM
Feb 19, 2026 12:00PM
Feb 10, 2026 04:50AM
Feb 10, 2026 03:15AM U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Takeda’s Oveporexton (TAK-861) as a Potential First-in-Class Therapy for Narcolepsy Type 1
Jan 29, 2026 01:37AM
Jan 22, 2026 07:45AM
Jan 22, 2026 07:45AM
Jan 14, 2026 09:00AM
Jan 5, 2026 07:03AM
Jan 5, 2026 07:00AM
Dec 18, 2025 03:00AM Takeda reports positive phase 3 results for zasocitinib psoriasis drug
Dec 18, 2025 03:00AM
Dec 8, 2025 02:54AM
Dec 6, 2025 09:30AM
Nov 7, 2025 11:01AM
Nov 7, 2025 11:00AM
Nov 3, 2025 08:33AM
Nov 3, 2025 07:00AM New Phase 3 Data Show Takeda’s Dengue Vaccine Delivers 7 Years of Sustained Protection Against Infection and Hospitalization
Oct 30, 2025 03:04AM
Oct 27, 2025 08:35AM
Oct 21, 2025 08:25PM
Oct 21, 2025 08:25PM
Sep 23, 2025 06:04PM
Sep 16, 2025 08:02AM
Sep 16, 2025 08:00AM Takeda and VELA to Ship Medicines Across the Atlantic Using First-of-its-Kind Wind-Powered Trimaran
Sep 11, 2025 08:45AM

1,186,524 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All